- Home
- BKE vs SDGR Comparison
BKE vs SDGR Comparison
Compare BKE & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKE
- SDGR
- Stock Information
- Founded
- BKE 1948
- SDGR 1990
- Country
- BKE United States
- SDGR United States
- Employees
- BKE N/A
- SDGR N/A
- Industry
- BKE Clothing/Shoe/Accessory Stores
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- BKE Consumer Discretionary
- SDGR Health Care
- Exchange
- BKE Nasdaq
- SDGR Nasdaq
- Market Cap
- BKE 2.0B
- SDGR 1.8B
- IPO Year
- BKE 1992
- SDGR 2020
- Fundamental
- Price
- BKE $37.75
- SDGR $19.89
- Analyst Decision
- BKE Hold
- SDGR Buy
- Analyst Count
- BKE 1
- SDGR 7
- Target Price
- BKE $41.00
- SDGR $32.29
- AVG Volume (30 Days)
- BKE 755.3K
- SDGR 900.4K
- Earning Date
- BKE 03-14-2025
- SDGR 04-30-2025
- Dividend Yield
- BKE 9.96%
- SDGR N/A
- EPS Growth
- BKE N/A
- SDGR N/A
- EPS
- BKE 3.89
- SDGR N/A
- Revenue
- BKE $1,217,689,000.00
- SDGR $207,539,000.00
- Revenue This Year
- BKE $2.41
- SDGR $28.69
- Revenue Next Year
- BKE $4.17
- SDGR $14.95
- P/E Ratio
- BKE $10.06
- SDGR N/A
- Revenue Growth
- BKE N/A
- SDGR N/A
- 52 Week Low
- BKE $34.67
- SDGR $16.67
- 52 Week High
- BKE $54.25
- SDGR $29.15
- Technical
- Relative Strength Index (RSI)
- BKE 41.99
- SDGR 39.42
- Support Level
- BKE $39.07
- SDGR $21.34
- Resistance Level
- BKE $39.98
- SDGR $22.85
- Average True Range (ATR)
- BKE 1.25
- SDGR 1.12
- MACD
- BKE 0.49
- SDGR -0.20
- Stochastic Oscillator
- BKE 62.78
- SDGR 5.06
About BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to better-priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.